Articles

Pulmonary Arterial Hypertension - Future Directions

Cardiac Resynchronisation Therapy - Evolving Strategies to Enhance Response

Citation:

European Cardiology 2010;6(1):83–7

Cost-effectiveness of Gadofosveset in the Management of Patients with Symptomatic Peripheral Arterial Occlusive Disease

Citation:

European Cardiology 2008;4(1):51–7

Erratum to: The Inhibitory Effects of Crucumin Glucuronide on p300-HAT Activity and Hypertrophic Phenylephrine- Induced Responses in Cardiomyocytes

Citation:

European Cardiology Review 2018;13(2):136.

Challenges in Oral Antiplatelet Therapy

Citation:

European Cardiology 2010:6(1):50-2

Implications of Remodelling in Atrial Fibrillation Therapy

Citation:

European Cardiology 2010;6(3):39–43

Cardiovascular Pharmacotherapy Focus

Published:

11 July 2019

Citation:

European Cardiology Review 2019;14(2):116

Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019’

Published:

15 July 2020

Citation:

European Cardiology Review 2020;15:e55.

VEGF-C and Cardiovascular Mortality in Patients Undergoing Drug-eluting Stent Implantation

Citation:

European Cardiology Review 2018;13(2):124.

The GATA4 Acetylation Site Plays a Key Role in the Development of Cardiomyocyte Hypertrophy

Citation:

European Cardiology Review 2018;13(2):125.